{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:12:06Z","timestamp":1776215526710,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,23]]},"DOI":"10.7759\/cureus.58838","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T16:46:39Z","timestamp":1713890799000},"source":"Crossref","is-referenced-by-count":3,"title":["From Skin to Blood: Ulcerative Pyoderma Gangrenosum Unveiling Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Sarra","family":"Chadli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Maamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"Khibri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Harmouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoubida","family":"Tazi Mezalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco E","year":"2009","unstructured":"Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009, 23:1008-17. 10.1111\/j.1468-3083.2009.03199.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.09.032","article-title":"Pyoderma gangrenosum in hematologic malignancies: a systematic review","volume":"82","author":"Montagnon CM","year":"2020","unstructured":"Montagnon CM, Fracica EA, Patel AA, et al.. Pyoderma gangrenosum in hematologic malignancies: a systematic review. J Am Acad Dermatol. 2020, 82:1346-59. 10.1016\/j.jaad.2019.09.032","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.11.063","article-title":"Neutrophilic dermatoses: pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses","volume":"79","author":"Ashchyan HJ","year":"2018","unstructured":"Ashchyan HJ, Nelson CA, Stephen S, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses: pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses. J Am Acad Dermatol. 2018, 79:1009-22. 10.1016\/j.jaad.2017.11.063","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/j4030028","article-title":"Pyoderma gangrenosum: a review of updates in diagnosis, pathophysiology and management","volume":"4","author":"Skopis M","year":"2021","unstructured":"Skopis M, Bag-Ozbek A. Pyoderma gangrenosum: a review of updates in diagnosis, pathophysiology and management. J. 2021, 4:3. 10.3390\/j4030028","journal-title":"J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum - a guide to diagnosis and management","volume":"19","author":"George C","year":"2019","unstructured":"George C, Deroide F, Rustin M. Pyoderma gangrenosum - a guide to diagnosis and management\u2002. Clin Med (Lond). 2019, 19:224-8. 10.7861\/clinmedicine.19-3-224","journal-title":"Clin Med (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(93)90109-P","article-title":"Pyoderma gangrenosum","volume":"11","author":"Duguid CM","year":"1993","unstructured":"Duguid CM, Powell FC. Pyoderma gangrenosum. Clin Dermatol. 1993, 11:129-33. 10.1016\/0738-081X(93)90109-P","journal-title":"Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts","volume":"154","author":"Maverakis E","year":"2018","unstructured":"Maverakis E, Ma C, Shinkai K, et al.. Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts. JAMA Dermatol. 2018, 154:461-6. 10.1001\/jamadermatol.2017.5980","journal-title":"JAMA Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients","volume":"8","author":"Al Ghazal P","year":"2013","unstructured":"Al Ghazal P, Herberger K, Schaller J, et al.. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis. 2013, 8:136. 10.1186\/1750-1172-8-136","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2015.05.003","article-title":"Pyoderma gangrenosum--a systemic disease?","volume":"33","author":"Wollina U","year":"2015","unstructured":"Wollina U. Pyoderma gangrenosum--a systemic disease?. Clin Dermatol. 2015, 33:527-30. 10.1016\/j.clindermatol.2015.05.003","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study","volume":"132","author":"Langan SM","year":"2012","unstructured":"Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012, 132:2166-70. 10.1038\/jid.2012.130","journal-title":"J Invest Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus AM","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011, 165:1244-50. 10.1111\/j.1365-2133.2011.10565.x","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan HJ","year":"2018","unstructured":"Ashchyan HJ, Butler DC, Nelson CA, et al.. The association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol. 2018, 154:409-13. 10.1001\/jamadermatol.2017.5978","journal-title":"JAMA Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn TN","year":"2006","unstructured":"Brooklyn TN, Dunnill MG, Shetty A, et al.. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006, 55:505-9. 10.1136\/gut.2005.074815","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-13-51","article-title":"UK dermatology clinical trials network\u2019s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum)\u202f: protocol for a randomised controlled trial","volume":"13","author":"Craig FF","year":"2012","unstructured":"Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD. UK dermatology clinical trials network\u2019s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum)\u202f: protocol for a randomised controlled trial. Trials. 2012, 13:51. 10.1186\/1745-6215-13-51","journal-title":"Trials"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1134939","article-title":"Practical aspects of the diagnosis and management of pyoderma gangrenosum","volume":"10","author":"Chen B","year":"2023","unstructured":"Chen B, Li W, Qu B. Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front Med (Lausanne). 2023, 10:1134939. 10.3389\/fmed.2023.1134939","journal-title":"Front Med (Lausanne)"},{"key":"ref16","article-title":"A comprehensive review of local pharmacologic therapy for pyoderma gangrenosum","volume":"31","author":"Baltazar D","year":"2019","unstructured":"Baltazar D, Haag C, Gupta AS, Marzano AM, Ortega Loayza AG. A comprehensive review of local pharmacologic therapy for pyoderma gangrenosum. Wounds. 2019, 31:151.","journal-title":"Wounds"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment","volume":"18","author":"Alavi A","year":"2017","unstructured":"Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2017, 18:355-72. 10.1007\/s40257-017-0251-7","journal-title":"Am J Clin Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod AD","year":"2015","unstructured":"Ormerod AD, Thomas KS, Craig FE, et al.. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ. 2015, 350:h2958. 10.1136\/bmj.h2958","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1709825","article-title":"Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum","volume":"13","author":"Goldust M","year":"2020","unstructured":"Goldust M, Hagstrom EL, Rathod D, Ortega-Loayza AG. Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum. Expert Rev Clin Pharmacol. 2020, 13:157-61. 10.1080\/17512433.2020.1709825","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2022.34.3.212","article-title":"Bullous variant of pyoderma gangrenosum in a patient with acute myeloid leukemia","volume":"34","author":"Kwon CI","year":"2022","unstructured":"Kwon CI, Lee GW, Kim CY. Bullous variant of pyoderma gangrenosum in a patient with acute myeloid leukemia. Ann Dermatol. 2022, 34:212-5. 10.5021\/ad.2022.34.3.212","journal-title":"Ann Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196271-from-skin-to-blood-ulcerative-pyoderma-gangrenosum-unveiling-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T16:47:45Z","timestamp":1713890865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196271-from-skin-to-blood-ulcerative-pyoderma-gangrenosum-unveiling-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.58838","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}